Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 Years with Cystic Fibrosis and at Least One F508del Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor

Vito Terlizzi, Cristina Fevola, Santiago Presti, Alice Castaldo, Valeria Daccò, Laura Claut, Angela Sepe, Fabio Majo, Rosaria Casciaro, Iréne Esposito, Pamela Vitullo, M Salvi, Patrizia Troiani, Francesca Ficili, Giuseppe Fabio Parisi, Stefano Pantano, Stefano Costa, Giuseppina Leonetti, Nicola Palladino, Giovanni Taccetti, Paolo Bonomi, Donatello Salvatore